PLX
Price
$1.84
Change
+$0.01 (+0.55%)
Updated
Dec 12, 02:07 PM (EDT)
Capitalization
147.17M
90 days until earnings call
Intraday BUY SELL Signals
SILO
Price
$0.44
Change
-$0.00 (-0.00%)
Updated
Dec 11 closing price
Capitalization
5.92M
Intraday BUY SELL Signals
Interact to see
Advertisement

PLX vs SILO

Header iconPLX vs SILO Comparison
Open Charts PLX vs SILOBanner chart's image
Protalix BioTherapeutics
Price$1.84
Change+$0.01 (+0.55%)
Volume$300
Capitalization147.17M
Silo Pharma
Price$0.44
Change-$0.00 (-0.00%)
Volume$70.87K
Capitalization5.92M
PLX vs SILO Comparison Chart in %
PLX
Daily Signal:
Gain/Loss:
SILO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PLX vs. SILO commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLX is a StrongBuy and SILO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (PLX: $1.83 vs. SILO: $0.44)
Brand notoriety: PLX and SILO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLX: 75% vs. SILO: 17%
Market capitalization -- PLX: $147.17M vs. SILO: $5.92M
PLX [@Biotechnology] is valued at $147.17M. SILO’s [@Biotechnology] market capitalization is $5.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLX’s FA Score shows that 0 FA rating(s) are green whileSILO’s FA Score has 0 green FA rating(s).

  • PLX’s FA Score: 0 green, 5 red.
  • SILO’s FA Score: 0 green, 5 red.
According to our system of comparison, PLX is a better buy in the long-term than SILO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLX’s TA Score shows that 6 TA indicator(s) are bullish while SILO’s TA Score has 4 bullish TA indicator(s).

  • PLX’s TA Score: 6 bullish, 4 bearish.
  • SILO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PLX is a better buy in the short-term than SILO.

Price Growth

PLX (@Biotechnology) experienced а +4.57% price change this week, while SILO (@Biotechnology) price change was -1.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.31%. For the same industry, the average monthly price growth was +4.75%, and the average quarterly price growth was +65.86%.

Reported Earning Dates

PLX is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+1.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLX($147M) has a higher market cap than SILO($5.92M). PLX YTD gains are higher at: -2.660 vs. SILO (-50.034). PLX has higher annual earnings (EBITDA): 10.4M vs. SILO (-4.88M). PLX has more cash in the bank: 33.4M vs. SILO (6.26M). SILO has less debt than PLX: SILO (18.9K) vs PLX (5.35M). PLX has higher revenues than SILO: PLX (61.9M) vs SILO (72.1K).
PLXSILOPLX / SILO
Capitalization147M5.92M2,482%
EBITDA10.4M-4.88M-213%
Gain YTD-2.660-50.0345%
P/E Ratio22.88N/A-
Revenue61.9M72.1K85,853%
Total Cash33.4M6.26M534%
Total Debt5.35M18.9K28,302%
FUNDAMENTALS RATINGS
PLX vs SILO: Fundamental Ratings
PLX
SILO
OUTLOOK RATING
1..100
131
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5298
PRICE GROWTH RATING
1..100
5986
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SILO's Valuation (55) in the null industry is in the same range as PLX (70) in the Servicestothe Health Industry industry. This means that SILO’s stock grew similarly to PLX’s over the last 12 months.

SILO's Profit vs Risk Rating (100) in the null industry is in the same range as PLX (100) in the Servicestothe Health Industry industry. This means that SILO’s stock grew similarly to PLX’s over the last 12 months.

PLX's SMR Rating (52) in the Servicestothe Health Industry industry is somewhat better than the same rating for SILO (98) in the null industry. This means that PLX’s stock grew somewhat faster than SILO’s over the last 12 months.

PLX's Price Growth Rating (59) in the Servicestothe Health Industry industry is in the same range as SILO (86) in the null industry. This means that PLX’s stock grew similarly to SILO’s over the last 12 months.

PLX's P/E Growth Rating (97) in the Servicestothe Health Industry industry is in the same range as SILO (100) in the null industry. This means that PLX’s stock grew similarly to SILO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PLXSILO
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 15 days ago
87%
Declines
ODDS (%)
Bearish Trend 23 days ago
80%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PLX
Daily Signal:
Gain/Loss:
SILO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LAW8.910.12
+1.37%
CS Disco
CRBG31.660.36
+1.15%
Corebridge Financial
XBIO2.420.02
+0.83%
Xenetic Biosciences
LFST6.760.01
+0.15%
LifeStance Health Group
ADVM4.36N/A
N/A
Adverum Biotechnologies

PLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLX has been loosely correlated with IOVA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PLX jumps, then IOVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
+1.67%
IOVA - PLX
45%
Loosely correlated
-0.44%
ADMA - PLX
34%
Loosely correlated
+2.00%
AURA - PLX
31%
Poorly correlated
+0.62%
STOK - PLX
31%
Poorly correlated
-3.10%
ZNTL - PLX
31%
Poorly correlated
+2.11%
More

SILO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SILO has been loosely correlated with SANA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SILO jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SILO
1D Price
Change %
SILO100%
+1.07%
SANA - SILO
34%
Loosely correlated
+1.21%
ALZN - SILO
33%
Loosely correlated
+0.93%
VIR - SILO
30%
Poorly correlated
+1.22%
SNTI - SILO
27%
Poorly correlated
-5.03%
CGEM - SILO
27%
Poorly correlated
-0.64%
More